Skip to main content
XRX
NASDAQ Technology

Xerox Posts $1.0B Q3 Loss on Goodwill Impairment, Slashes Guidance and Suspends Dividends

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: IT Services Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$2.05
Mkt Cap
$366.367M
52W Low
$1.19
52W High
$3.78
52W Position info
72% above low
Off High info
46% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

XRX sits 72% above its 52-week low of $1.19 on elevated volume (2.9× avg).

Summary

Xerox reported a $1,015 million Q3 net loss including a $959 million non-cash goodwill impairment, cut full-year free cash flow guidance to $50-100 million from $250 million, and suspended its common and preferred dividends to preserve cash.

Updates

  1. · Reuters — Xerox's Q3 adjusted EPS was 2 cents, beating the 4-cent loss expected, on revenue of $1.87 billion versus $1.86 billion expected.


Key Events · Earnings and Guidance · XRX

  • Q3 Swings to $1.0B Net Loss

    GAAP net loss of $(1,015) million, or $(7.73) per share, versus $(760) million a year earlier, on revenue of $1.87 billion, down 4.7%.

  • $959M Non-Cash Goodwill Impairment

    A $959 million pre-tax ($955 million after-tax, $6.87 per share) impairment on the Print and Other reporting unit after lowered projections tied to macro uncertainty and sustained memory price increases.

  • Guidance Cut and Dividend Suspended

    Full-year adjusted operating income guidance cut to $450-475 million from $555-605 million and free cash flow to $50-100 million from $250 million; common and preferred dividends suspended to preserve cash.

  • Cash Generation Deteriorates

    Q3 operating cash flow of $30 million, down $86 million year-over-year, and free cash flow of $7 million, down $81 million, with cash and equivalents at $412 million against $4.06 billion of long-term debt.


Analysis · XRX · Technology

The headline loss is largely accounting: a $959 million non-cash goodwill impairment on the Print and Other unit, taken after management lowered its long-term projections for that business, drove a $1,015 million net loss in Q3. The cash story is the bigger problem. Full-year free cash flow guidance was cut to $50-100 million from $250 million, and adjusted operating income guidance fell to $450-475 million from $555-605 million. To preserve cash, the company suspended both common and preferred dividends — a stark admission that the turnaround is not generating enough liquidity. Adjusted operating margin did improve to 6.6% from 3.3%, but that is cold comfort against a balance sheet with $4.06 billion of long-term debt and shareholders' equity now negative at $(683) million. The impairment is accounting, not cash, but the guidance cut and dividend suspension are real.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 47.6% of the 231 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XRX was trading at $2.05 on NASDAQ in the Technology sector, with a market capitalization of approximately $366.4M. The 52-week trading range was $1.19 to $3.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XRX - Latest Insights

XRX
Oct 29, 2026, 10:40 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.69
Real-time Price: $1.77 info
Change: +$0.082 (+5%) info
Market Cap: $231.114M info
XRX
Oct 29, 2026, 8:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.77 info
Change: -$0.203 (-10%) info
Market Cap: $231.114M info
XRX
Oct 29, 2026, 6:35 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.26
Real-time Price: $1.77 info
Change: -$0.493 (-22%) info
Market Cap: $231.114M info
XRX
Oct 29, 2026, 6:35 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.77 info
Change: -$0.533 (-23%) info
Market Cap: $231.114M info
XRX
Oct 19, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $2.50
Real-time Price: $1.77 info
Change: -$0.7315 (-29%) info
Market Cap: $231.114M info